Dr. Reddy's Laboratories is recalling approximately 1,350 bottles and 147 cartons of Imatinib Mesylate tablets (100mg), a prescription medication used to treat certain types of cancer. The recall was initiated because the tablets failed dissolution specifications, meaning they may not dissolve properly in the body as intended. This defect can lead to the medication being less effective than required for treatment. These products were distributed nationwide across the United States in both 90-count bottles and 30-count cartons for institutional use.
If the medication fails to dissolve correctly, the patient may not receive the full intended dose of the drug. This could result in decreased effectiveness of the cancer treatment, potentially allowing the underlying condition to worsen.
Healthcare provider consultation and pharmacy return
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.